SOUTH TEXAS HEALTH SYSTEM
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $159K
- Transactions
- 59
- Companies
- 21
- Average per transaction
- $2,693
Who reported the payments
| Hill-rom Holdings, Inc | $95,538 |
| Penumbra, Inc. | $20,395 |
| CSL Behring | $7,500 |
| AstraZeneca | $7,000 |
| Nonin Medical, Inc. | $4,526 |
| Medical Device Business Services, Inc. | $4,000 |
| Scientia Vascular | $3,821 |
| Fisher Scientific Company L.L.C. | $3,790 |
| Aesculap, Inc. | $2,901 |
| Qiagen, LLC | $1,454 |
| Stryker | $1,418 |
| KARL Storz Endoscopy-america | $1,112 |
| Abbott | $1,105 |
| Chiesi USA, Inc. | $1,000 |
| Baxter Healthcare | $1,000 |
| Convatec Inc. | $1,000 |
| Organon | $700 |
| Hikma Pharmaceuticals USA | $235 |
| Cochlear Americas | $194 |
| Kedrion Biopharma Inc. | $148 |
| Bio-rad Laboratories, Inc. | $65 |